NCT01633255 2019-12-17
[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment
National Institutes of Health Clinical Center (CC)
Phase 1/2 Withdrawn
Clinical Trials
4 trialsNCT01492192 2017-11-01
RGD-PET-CT in Cancer Angiogenesis
Oxford University Hospitals NHS Trust
Phase 2 Terminated
NCT01961583 2016-03-01
[18F]Fluciclatide PET Imaging of Pazopanib Response
Asan Medical Center
Phase 2 Terminated
NCT00918281 2014-06-09
Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection
GE Healthcare
Phase 2 Completed